Evaluating the Efficacy and Safety of Long-Acting Lenacapavir for HIV PrEP
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Injectable PrEP | Lenacapavir | HIV/AIDS | Healthy Volunteers | PrEP
Age: Between 16 - 100 Years
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required